Miguel J. Bernardes

Porto, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 126 publications

The impact of smoking and obesity on secukinumab effectiveness in psoriatic arthritis: real-world evidence from 1202 European patients.

The impact of smoking and obesity on secukinumab effectiveness in psoriatic arthritis: real-world evidence from 1202 European patients.

Journal: EULAR rheumatology open

Published: June 29, 2026

Influence of national socioeconomic status on treatment retention and disease activity in psoriatic arthritis and axial spondyloarthritis: evidence over 2 years in 13 European countries.

Influence of national socioeconomic status on treatment retention and disease activity in psoriatic arthritis and axial spondyloarthritis: evidence over 2 years in 13 European countries.

Journal: Annals of the rheumatic diseases

Published: February 11, 2026

Real-world safety data of first-line drugs for rheumatoid arthritis: insights from the Portuguese Reuma.pt database.

Real-world safety data of first-line drugs for rheumatoid arthritis: insights from the Portuguese Reuma.pt database.

Journal: ARP rheumatology

Published: January 02, 2026

Interstitial lung disease in Sjögren's disease: the portrait of a national cohort.

Interstitial lung disease in Sjögren's disease: the portrait of a national cohort.

Journal: ARP rheumatology

Published: January 02, 2026

Impact of cardiometabolic comorbidities on clinical characteristics, prescription patterns and retention rate of first b/tsDMARD treatment in 5299 European real-world patients with psoriatic arthritis.

Impact of cardiometabolic comorbidities on clinical characteristics, prescription patterns and retention rate of first b/tsDMARD treatment in 5299 European real-world patients with psoriatic arthritis.

Journal: RMD open

Published: October 28, 2025

Tocilizumab as a treatment option in Sjögren disease with associated lymphocytic interstitial pneumonia.

Tocilizumab as a treatment option in Sjögren disease with associated lymphocytic interstitial pneumonia.

Journal: Clinical rheumatology

Published: July 24, 2025

Is the association between Immunoglobulin A Nephropathy and Spondyloarthritis real? A case-based review.

Is the association between Immunoglobulin A Nephropathy and Spondyloarthritis real? A case-based review.

Journal: ARP rheumatology

Published: April 02, 2025

Understanding difficult-to-treat psoriatic arthritis: Data from the Rheumatic Diseases Portuguese Registry.

Understanding difficult-to-treat psoriatic arthritis: Data from the Rheumatic Diseases Portuguese Registry.

Journal: Joint bone spine

Published: March 29, 2025

The use of ASDAS to evaluate disease activity and response to treatment in patients with axial spondyloarthritis starting the first biological drug: Are ASAS recommendations being followed?

The use of ASDAS to evaluate disease activity and response to treatment in patients with axial spondyloarthritis starting the first biological drug: Are ASAS recommendations being followed?

Journal: Seminars in arthritis and rheumatism

Published: March 15, 2025

Subacute skin lesions in systemic lupus erythematosus: an impressive and well-tolerated response to anifrolumab.

Subacute skin lesions in systemic lupus erythematosus: an impressive and well-tolerated response to anifrolumab.

Journal: Anais brasileiros de dermatologia

Published: March 13, 2025

Chronic inflammatory demyelinating polyneuropathy associated with active systemic lupus erythematous: Anifrolumab as a potentially successful add-on therapy to intravenous immunoglobulins.

Chronic inflammatory demyelinating polyneuropathy associated with active systemic lupus erythematous: Anifrolumab as a potentially successful add-on therapy to intravenous immunoglobulins.

Journal: Lupus

Published: January 17, 2025

Biologic disease-modifying antirheumatic drugs survival in late-onset axial spondyloarthritis - data from a Portuguese registry.

Biologic disease-modifying antirheumatic drugs survival in late-onset axial spondyloarthritis - data from a Portuguese registry.

Journal: Rheumatology (Oxford, England)

Published: January 08, 2025

Showing 1-12 of 126

Last Updated: 09/26/2026